Both in Pharmaceuticals
Cellectar Biosciences INC NEW vs Lipocine
Over the past year CLRB returned −60.3% and LPCN returned −44.9%; their daily moves had a correlation of 0.06.
CLRB −60.3% LPCN −44.9%Growth of $1, one year, split-adjusted
| Metric | CLRB | LPCN |
|---|---|---|
| Price | $1.31 | $1.46 |
| Market cap | $12.4M | $12.0M |
| Today | +7.38% | +0.69% |
| 1 month | −21.6% | −29.5% |
| 6 months | −58.8% | −37.3% |
| Year to date | −55.6% | −81.8% |
| 1 year | −61.4% | −45.1% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 9.6× |
| Net cash | $34.0M | $23.3M |
| Dividend yield | — | — |
| Volatility (60d) | 68.1% | 57.5% |
| Short % of float | 2.9% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).